Hyperinflammation and Hyperferritinemia in Critically Ill Patients
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCharles University, Czech Republic
About this trial
Analysing trajectory of critically ill patients with signs of hyperinflammation
Eligibility criteria
Qualifiers
critically ill patients
admission between 01.01.2020 and 31.12.2024 (5yrs)
Disqualifiers
none
Trial design
Treatments tested in this trial
- Not listed
Trial groups
1,962 Participants
are grouped into 1 trial groupLocations
1Faculty of Medicine and Teaching Hospital, Charles University30460, PilsenCzech Republic, Czechia
Sponsors and collaborators
Charles University, Czech Republic
Lead sponsor
Source ClinicalTrials.gov